| Page 7 | Progress In Mind

Home

Bipolar, Schizophrenia

Highlighted studies in psychosis

New light cast on links between mental illness and creativity; inflammatory pathways that may be...

Future of schizophrenia treatment: Where do we go now?

Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...

Congress highlights

Severity and Treatment of Depression: A Review of Two Controversies

Antidepressants are not limited to severely depressed patients, and psychotherapy is not limited to...

Congress highlights

Digital technology and the patient experience - what are the opportunities and challenges of ‘mHealth’?

Digital technology has already transformed the way we work, but, maybe surprisingly, has yet to...

Congress highlights

Psychiatry’s white whale? The search for biomarkers for schizophrenia

Biomarkers are available and used effectively in other disorders– notably some of the cancers...

Congress highlights

Urgent need to optimize treatment in major depression

Residual symptoms reduce the likelihood of return to pre-depression functioning and increase the...

Congress highlights

Tackling the elephant in the room: non-adherence in schizophrenia

The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways...

Depression, Schizophrenia

What are you doing to celebrate World Mental Health Day?

We asked advocacy groups from all around the world why it is important to support World Mental...

Congress highlights

Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?

‘Functioning’ is a broad term, and encompasses the individual’s ability to...

Congress highlights

Treating cognitive symptoms improves workplace productivity

The new paradigm for the treatment of major depressive disorder (MDD) is to “make patients...

Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies

The results of an online survey completed by 204 US psychiatrists on the clinical impact of...

Schizophrenia – from prodrome to psychosis

Psychosis is preceded by a 3–4 year prodromal phase in 75% of patients, but only 25% of...

Medical education resource center

Do you want to learn more?

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Ireland Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Portugal
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline